Berkow S E, Spear M L, Stahl G E, Gutman A, Polin R A, Pereira G R, Olivecrona T, Hamosh P, Hamosh M
Department of Pediatrics, Georgetown University Medical Center, Washington, D.C. 20007.
J Pediatr Gastroenterol Nutr. 1987 Jul-Aug;6(4):581-8. doi: 10.1097/00005176-198707000-00016.
Plasma lipolytic activity (lipoprotein lipase and hepatic lipase), free fatty acids (FFA), triglycerides, cholesterol, and glucose levels were measured in 21 premature infants [gestational age 26-37 weeks (mean +/- SEM 30.4 +/- 0.63 weeks), aged 1-8 days (mean +/- SEM 3.00 +/- 0.35 days)]. All infants were maintained on total parenteral nutrition with heparin (1 U/ml) and were given Intralipid, 1, 2, and 3 g/kg/day, over 15 h on days 1, 2, and 3, respectively. Blood samples were drawn before and at the end of Intralipid administration. Baseline plasma lipolytic activity, before the start of lipid infusion, was 1.54 +/- 0.24 U/ml (1 U = 1 mumol [3H]oleic acid released from tri[3H]olein/h). Lipolytic activity increased after lipid infusion to 4.04 +/- 0.96, 4.32 +/- 0.63, and 6.09 +/- 1.00 U/ml on days 1, 2, and 3 of the study. Hepatic lipase amounted to 38-47% of total lipolytic activity. During the 3 days of lipid infusion, there were dose-dependent increases in plasma FFA, triglyceride, and cholesterol. Whereas FFA and triglyceride concentrations returned to prelipid infusion levels 9 h after stopping the infusion of Intralipid, 1, 2, or 3 g/kg, there was a cumulative increase in plasma cholesterol and glucose concentrations. The close correlation between FFA concentrations and plasma lipolytic activity (r = 0.655, p less than 0.001) suggests considerable intravascular lipolysis. The positive correlation between plasma FFA and triglycerides (r = 0.632, p less than 0.001) and FFA and cholesterol (r = 0.582, p less than 0.001) indicate, however, that intravascular lipolysis does not prevent the lipemia associated with Intralipid infusion to low birth weight infants.(ABSTRACT TRUNCATED AT 250 WORDS)
对21名早产儿[胎龄26 - 37周(平均±标准误30.4±0.63周),年龄1 - 8天(平均±标准误3.00±0.35天)]测量了血浆脂解活性(脂蛋白脂肪酶和肝脂肪酶)、游离脂肪酸(FFA)、甘油三酯、胆固醇和葡萄糖水平。所有婴儿均接受含肝素(1 U/ml)的全胃肠外营养,并分别在第1、2和3天,在15小时内给予1、2和3 g/kg/天的英脱利匹特。在英脱利匹特给药前及给药结束时采集血样。脂质输注开始前的基线血浆脂解活性为1.54±0.24 U/ml(1 U = 1 μmol [3H]油酸从三[3H]油精释放/小时)。在研究的第1、2和3天,脂质输注后脂解活性分别增加至4.04±0.96、4.32±0.63和6.09±1.00 U/ml。肝脂肪酶占总脂解活性的38 - 47%。在脂质输注的3天期间,血浆FFA、甘油三酯和胆固醇呈剂量依赖性增加。当停止输注1、2或3 g/kg的英脱利匹特9小时后,FFA和甘油三酯浓度恢复到脂质输注前水平,但血浆胆固醇和葡萄糖浓度有累积增加。FFA浓度与血浆脂解活性之间的密切相关性(r = 0.655,p < 0.001)表明存在相当程度的血管内脂解。然而,血浆FFA与甘油三酯之间的正相关性(r = 0.632,p < 0.001)以及FFA与胆固醇之间的正相关性(r = 0.582,p < 0.001)表明,血管内脂解并不能防止与给低出生体重婴儿输注英脱利匹特相关的脂血症。(摘要截断于250字)